SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    R. N. Ambade, S. N. Shinde, M. S. A. Khan, S. P. Lohar, K. V. Vimalnath, P. V. Joshi, Sudipta Chakraborty, M. R. A. Pillai, Ashutosh Dash, Development of a dry distillation technology for the production of 131I using medium flux reactor for radiopharmaceutical applications, Journal of Radioanalytical and Nuclear Chemistry, 2015, 303, 1, 451

    CrossRef

  2. 2
    Wendy Sacks, RONNIE WONG, Catherine Bresee, Glenn Braunstein, Use of Evidence-Based Guidelines Reduces I131 Treatment in Patients with Low Risk Differentiated Thyroid Cancer, Thyroid, 2015, 150127064143005

    CrossRef

  3. 3
    Melanie Goldfarb, Stephen F. Sener, Comparison of Radioiodine Utilization in Adolescent and Young Adult and Older Thyroid Cancer Patients, Endocrine Practice, 2014, 20, 5, 405

    CrossRef

  4. 4
    Jose P. Zevallos, Li Xu, Yin Yiu, The Impact of Socioeconomic Status on the Use of Adjuvant Radioactive Iodine for Papillary Thyroid Cancer, Thyroid, 2014, 24, 4, 758

    CrossRef

  5. 5
    Maria Papaleontiou, Mousumi Banerjee, Di Yang, James C. Sisson, Ronald J. Koenig, Megan R. Haymart, Factors That Influence Radioactive Iodine Use for Thyroid Cancer, Thyroid, 2013, 23, 2, 219

    CrossRef

  6. 6
    Megan R. Haymart, Mousumi Banerjee, Di Yang, Andrew K. Stewart, Jennifer J. Griggs, James C. Sisson, Ronald J. Koenig, Referral Patterns for Patients with High-Risk Thyroid Cancer, Endocrine Practice, 2013, 19, 4, 638

    CrossRef

  7. 7
    Kathryn M. Schuessler, Mousumi Banerjee, Di Yang, Andrew K. Stewart, Gerard M. Doherty, Megan R. Haymart, Surgeon Training and Use of Radioactive Iodine in Stage I Thyroid Cancer Patients, Annals of Surgical Oncology, 2013, 20, 3, 733

    CrossRef

  8. 8
    Frederik A. Verburg, Heribert Hänscheid, Markus Luster, Thyroid remnant ablation in differentiated thyroid carcinoma: when and how, Clinical and Translational Imaging, 2013, 1, 3, 195

    CrossRef